Antimicrobials
Fidaxomicin

Fidaxomicin

C difficile risk
None
Oral Bioavailability
None

Dosing

C. difficile 200mg PO BID x 10 days

General Information

C. difficile colitis

  • GI disturbance

  • Cytopenias

  • Hypersensitivity: facial, tongue or throat swelling

Consult Infectious Disease

Antimicrobial class: Specialized anti-C. difficile macrocyclic agent

Pregnancy category: B

Biliary penetration: None

CSF penetration: None

Lung penetration: None

Urine penetration: None